Dextromethorphan toxicity: reversal by naloxone. 1977

W L Shaul, and M Wandell, and W O Robertson

Naloxone has been shown to be effective in antagonizing the effects of a number of narcotic and related drugs. Its successful use in managing a patient with an overdose of dextromethorphan extends its application as a specific antidote.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007981 Levorphanol A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection. Levorphan,3-Hydroxy-N-methylmorphinan,L-Dromoran,Levo-Dromoran,Levodroman,Levorphanol Tartrate,3 Hydroxy N methylmorphinan,L Dromoran,Levo Dromoran,LevoDromoran,Tartrate, Levorphanol
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D011041 Poisoning A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. Poisonings
D003915 Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity. d-Methorphan,Delsym,Dextromethorphan Hydrobromide,Dextromethorphan Hydrobromide, (+-)-Isomer,Dextromethorphan Hydrobromide, Monohydrate,Dextromethorphan Hydrochloride,Dextromethorphan, (+-)-Isomer,Racemethorphan,Hydrobromide, Dextromethorphan,Hydrochloride, Dextromethorphan
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W L Shaul, and M Wandell, and W O Robertson
October 1986, Annals of emergency medicine,
W L Shaul, and M Wandell, and W O Robertson
May 1991, The American journal of emergency medicine,
W L Shaul, and M Wandell, and W O Robertson
October 2018, Clinical toxicology (Philadelphia, Pa.),
W L Shaul, and M Wandell, and W O Robertson
February 2023, Cureus,
W L Shaul, and M Wandell, and W O Robertson
April 1982, Annals of internal medicine,
W L Shaul, and M Wandell, and W O Robertson
January 2009, BMJ case reports,
W L Shaul, and M Wandell, and W O Robertson
November 1978, Lancet (London, England),
W L Shaul, and M Wandell, and W O Robertson
July 1976, Endocrinology,
W L Shaul, and M Wandell, and W O Robertson
September 2007, Emergency medicine journal : EMJ,
W L Shaul, and M Wandell, and W O Robertson
April 2019, Journal of medical toxicology : official journal of the American College of Medical Toxicology,
Copied contents to your clipboard!